科学研究 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research
Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials
Limitations of Repeat Revascularization as an Outcome Measure

Recommandation Statement

2019 Feb 21:CIR0000000000000641.

JOURNAL：Circulation.

Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association

Campia U, American Heart Association Council on Peripheral Vascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Cardiovascular and Stroke Nursing.

21370

Keywords: AHA Scientific Statements; cardiovascular diseases; medical oncology; therapeutics

FULL TEXT PDF